Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain

2003 ◽  
Vol 21 (7) ◽  
pp. 803-806 ◽  
Author(s):  
Xueding Wang ◽  
Yongjiang Pang ◽  
Geng Ku ◽  
Xueyi Xie ◽  
George Stoica ◽  
...  
2019 ◽  
Vol 5 (12) ◽  
pp. 2003-2013 ◽  
Author(s):  
Takeshi Fuchigami ◽  
Masao Kawasaki ◽  
Ryusuke Koyama ◽  
Mari Nakaie ◽  
Takehiro Nakagaki ◽  
...  
Keyword(s):  

2011 ◽  
Vol 21 (14) ◽  
pp. 4193-4196 ◽  
Author(s):  
Mengchao Cui ◽  
Masahiro Ono ◽  
Hiroyuki Kimura ◽  
Boli Liu ◽  
Hideo Saji

Author(s):  
Verena Heise ◽  
Enikő Zsoldos ◽  
Klaus P. Ebmeier

There is little doubt that the brain changes with time, and all research in psychiatry is predicated on holding age constant in comparing groups of patients or estimating the effect sizes of causal factors. Nevertheless, relatively little is known about the mechanisms that are responsible for translating time into ageing. This chapter tries, after an overview of the principal mechanisms involved in biological ageing, to summarize the age-related changes observable in brains in vivo and to demonstrate the types of investigations that may cast light on such mechanisms in the future. A useful heuristic device to order the multiple potential causes of ageing is the chronic stress–allostatic load model, widely employed in epidemiology, public health medicine, and health psychology. In vivo imaging provides a method to test the translation of intermediate stress markers, such as vascular risk, metabolic syndrome, or allostatic load, into predictors of age-related brain changes.


2020 ◽  
Vol 21 (21) ◽  
pp. 8048
Author(s):  
Marie A. Labouesse ◽  
Reto B. Cola ◽  
Tommaso Patriarchi

Understanding how dopamine (DA) encodes behavior depends on technologies that can reliably monitor DA release in freely-behaving animals. Recently, red and green genetically encoded sensors for DA (dLight, GRAB-DA) were developed and now provide the ability to track release dynamics at a subsecond resolution, with submicromolar affinity and high molecular specificity. Combined with rapid developments in in vivo imaging, these sensors have the potential to transform the field of DA sensing and DA-based drug discovery. When implementing these tools in the laboratory, it is important to consider there is not a ‘one-size-fits-all’ sensor. Sensor properties, most importantly their affinity and dynamic range, must be carefully chosen to match local DA levels. Molecular specificity, sensor kinetics, spectral properties, brightness, sensor scaffold and pharmacology can further influence sensor choice depending on the experimental question. In this review, we use DA as an example; we briefly summarize old and new techniques to monitor DA release, including DA biosensors. We then outline a map of DA heterogeneity across the brain and provide a guide for optimal sensor choice and implementation based on local DA levels and other experimental parameters. Altogether this review should act as a tool to guide DA sensor choice for end-users.


2005 ◽  
Vol 48 (23) ◽  
pp. 7253-7260 ◽  
Author(s):  
Masahiro Ono ◽  
Naoko Yoshida ◽  
Kenichi Ishibashi ◽  
Mamoru Haratake ◽  
Yasushi Arano ◽  
...  

Science ◽  
2012 ◽  
Vol 335 (6075) ◽  
pp. 1458-1462 ◽  
Author(s):  
L. V. Wang ◽  
S. Hu

Sign in / Sign up

Export Citation Format

Share Document